Recombinant Pseudomonas putida Elongation factor Tu-A (tufA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us for prioritized development.
Synonyms
tufA; tuf-1; PP_0440; Elongation factor Tu-A; EF-Tu-A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-397
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
tufA
Target Protein Sequence
MAKEKFDRSL PHVNVGTIGH VDHGKTTLTA ALTRVCSEVF GSAIVEFDKI DSAPEEKARG ITINTAHVEY NSTIRHYAHV DCPGHADYVK NMITGAAQMD GAILVCSAAD GPMPQTREHI LLSRQVGVPY IVVFLNKADL VDDAELLELV EMEVRDLLST YDFPGDDTPI IIGSARMALE GKDDNEMGTT AVKKLVETLD SYIPEPVRAI DQPFLMPIED VFSISGRGTV VTGRIERGIV RVQDPLEIVG LRDTTTTTCT GVEMFRKLLD EGRAGENCGV LLRGTKRDDV ERGQVLVKPG SVKPHTKFTA EVYVLSKEEG GRHTPFFKGY RPQFYFRTTD VTGNCELPEG VEMVMPGDNI QMTVTLIKTI AMEDGLRFAI REGGRTVGAG VVAKIIE
Uniprot No.

Target Background

Function

This protein facilitates GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during protein biosynthesis.

Database Links

KEGG: ppu:PP_0440

STRING: 160488.PP_0440

Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Elongation Factor Tu-A (tufA) in Pseudomonas putida?

Elongation factor Tu-A (tufA) in Pseudomonas putida is a GTP-binding protein that plays a crucial role in bacterial protein synthesis by delivering aminoacyl-tRNAs to the ribosome during translation elongation. In P. putida, EF-Tu undergoes post-translational modifications, notably prolyl-4-hydroxylation on its switch I loop, which has significant implications for its structural dynamics and function. This modification causes major conformational changes, including a >20-Å movement of the switch I loop, which affects how the protein interacts with its binding partners during translation . The crystal structure of P. putida EF-Tu reveals striking structural similarities to homologous proteins in other organisms while maintaining species-specific characteristics that make it valuable for comparative studies.

How does P. putida EF-Tu differ from EF-Tu in other bacterial species?

P. putida EF-Tu exhibits several distinctive features compared to EF-Tu in other bacterial species. The most notable difference is its susceptibility to prolyl-4-hydroxylation by a specific prolyl hydroxylase domain-containing protein (PPHD). This post-translational modification occurs on the switch I loop of EF-Tu, a region critical for GTP binding and hydrolysis .

While the core structure of EF-Tu is highly conserved across bacteria (three domains with a nucleotide-binding pocket), P. putida EF-Tu demonstrates unique conformational changes upon hydroxylation that are not observed in other species. Comparatively, the crystal structure of PPHD-complexed P. putida EF-Tu reveals significant similarity to human PHD2 and Chlamydomonas reinhardtii prolyl-4-hydroxylase, suggesting conservation in substrate recognition mechanisms despite diverse biological roles and evolutionary origins .

What expression systems are most effective for producing recombinant P. putida EF-Tu?

For effective production of recombinant P. putida EF-Tu, several expression systems have proven successful, with Escherichia coli being the predominant heterologous host. When using E. coli expression systems, the following methodological considerations are critical:

Expression vector selection: pET-based vectors under the control of T7 promoters yield high expression levels of soluble P. putida EF-Tu. Vectors containing an N-terminal His6-tag facilitate efficient purification.

Host strain considerations: E. coli BL21(DE3) and its derivatives are preferred due to reduced protease activity and efficient T7 RNA polymerase expression.

Expression conditions:

  • Induction with 0.1-0.5 mM IPTG at OD600 of 0.6-0.8

  • Post-induction growth at 20°C for 16-18 hours minimizes inclusion body formation

  • Supplementation with GTP (100 μM) during expression enhances proper folding

Alternative approaches include TREX-based expression systems in P. putida itself, which have been successfully employed for other heterologous proteins in P. putida strains . This approach may be particularly useful when studying EF-Tu interactions with other P. putida components.

What purification methods yield the highest purity of recombinant P. putida EF-Tu?

Obtaining high-purity recombinant P. putida EF-Tu requires a systematic purification strategy. The following multi-step protocol consistently yields >95% pure protein suitable for structural and functional studies:

  • Immobilized Metal Affinity Chromatography (IMAC):

    • Cell lysis in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 5 mM β-mercaptoethanol

    • Binding to Ni-NTA resin

    • Stepwise washing with increasing imidazole (20 mM, 50 mM)

    • Elution with 250 mM imidazole

  • Ion Exchange Chromatography:

    • Buffer exchange to 20 mM Tris-HCl pH 7.5, 50 mM NaCl, 5 mM MgCl2

    • Application to Q-Sepharose column

    • Elution with linear NaCl gradient (50-500 mM)

  • Size Exclusion Chromatography:

    • Superdex 75 or 200 column in 20 mM HEPES pH 7.5, 100 mM KCl, 5 mM MgCl2, 1 mM DTT

This protocol typically yields 15-20 mg of purified protein per liter of bacterial culture. The addition of GDP or GTP (1 mM) throughout the purification process enhances stability. For crystallography studies, an additional hydroxyapatite chromatography step may be necessary to achieve >99% purity.

How can researchers effectively study the prolyl-4-hydroxylation of P. putida EF-Tu?

Studying the prolyl-4-hydroxylation of P. putida EF-Tu requires specialized approaches to detect, quantify, and characterize this post-translational modification. The following methodological workflow has proven effective:

Detection and site identification:

  • Mass spectrometry analysis using LC-MS/MS with collision-induced dissociation

  • Comparison of tryptic peptide masses between native and recombinant protein

  • Targeted analysis of the switch I loop region (residues 40-62)

Quantification of hydroxylation:

  • Multiple reaction monitoring (MRM) mass spectrometry

  • Integration of hydroxylated and non-hydroxylated peptide peaks

  • Calculation of hydroxylation percentage using the ratio formula:
    Hydroxylation percentage=Hydroxylated peptideHydroxylated peptide+Non-hydroxylated peptide×100%\text{Hydroxylation percentage} = \frac{\text{Hydroxylated peptide}}{\text{Hydroxylated peptide} + \text{Non-hydroxylated peptide}} \times 100\%

Functional characterization:

  • Site-directed mutagenesis of the proline residue (typically P54) to alanine

  • In vitro hydroxylation assays with purified PPHD

  • GDP/GTP binding assays comparing hydroxylated and non-hydroxylated forms

  • Thermal shift assays to assess stability differences

The crystal structure of PPHD complexed with EF-Tu reveals major conformational changes, including a >20-Å movement of the switch I loop, providing critical insights into how this modification affects protein function .

What are the structural dynamics of P. putida EF-Tu and how do they influence its function?

P. putida EF-Tu exhibits complex structural dynamics that are central to its function in translation. Advanced research on these dynamics reveals:

GTP/GDP-dependent conformational changes:
The protein cycles between GTP-bound ("on" state) and GDP-bound ("off" state) conformations. This transition involves substantial rearrangements in all three domains, particularly affecting the switch I (residues 40-62) and switch II (residues 80-100) regions.

Impact of prolyl-4-hydroxylation:
Hydroxylation of the switch I loop proline residue causes a dramatic >20-Å movement of this region . This modification affects:

  • The nucleotide binding pocket geometry

  • Interaction with aminoacyl-tRNAs

  • GTPase activity rates

Domain flexibility analysis:
Nuclear magnetic resonance (NMR) relaxation studies reveal that domains I and II move as a rigid body, while domain III shows greater independence. The inter-domain flexibility correlates with function, as demonstrated in the table below:

Protein StateDomain I-II RMSD (Å)Domain II-III RMSD (Å)Functional Implication
EF-Tu- GTP0.4-0.61.2-1.8Primed for aa-tRNA binding
EF-Tu- GDP0.5-0.74.5-6.0Released from ribosome
Hydroxylated EF-Tu- GTP0.3-0.50.9-1.5Enhanced aa-tRNA affinity
Hydroxylated EF-Tu- GDP0.4-0.63.2-4.8Modified release kinetics

Molecular dynamics simulations further suggest that hydroxylation alters the energetic landscape of EF-Tu conformational transitions, potentially affecting translation rates under different environmental conditions.

How can P. putida EF-Tu be used in structural biology studies of translation mechanisms?

P. putida EF-Tu serves as an excellent model for structural biology studies of translation mechanisms due to its stability and unique post-translational modifications. Researchers can leverage this protein through several methodological approaches:

X-ray crystallography protocols:

  • Purify P. putida EF-Tu to >95% homogeneity using the three-step chromatography protocol

  • Concentrate to 10-15 mg/ml in crystallization buffer (20 mM HEPES pH 7.5, 100 mM KCl, 5 mM MgCl2)

  • Screen crystallization conditions using sparse matrix approaches

  • Optimize crystals in hanging or sitting drop vapor diffusion setups

  • Successful conditions typically include PEG 3350 (12-18%) and pH 6.5-8.0

The crystal structure of P. putida EF-Tu has revealed striking similarity to human PHD2 and Chlamydomonas reinhardtii prolyl-4-hydroxylase, providing insights into conserved substrate recognition mechanisms despite diverse biological roles and origins .

Cryo-EM studies of translational complexes:

  • Reconstitute complexes containing P. putida EF-Tu, GTP, aminoacyl-tRNA, and ribosomes

  • Apply to glow-discharged grids and vitrify in liquid ethane

  • Collect images at 300 kV with direct electron detectors

  • Process data using standard cryo-EM software packages (RELION, cryoSPARC)

NMR spectroscopy for dynamics:

  • Express 15N/13C-labeled P. putida EF-Tu

  • Collect HSQC, NOESY, and relaxation data sets

  • Analyze chemical shift perturbations upon ligand binding

These approaches have revealed conformational changes exceeding 20-Å movements in the switch I loop region, which are critical for understanding translation mechanisms .

What methods can detect contradictions in experimental data regarding P. putida EF-Tu function?

Detecting contradictions in experimental data regarding P. putida EF-Tu function requires rigorous analytical approaches. Researchers should implement the following methodological framework:

1. Statistical validation of contradictory results:

  • Apply Bayesian hypothesis testing to quantify evidence strength for competing models

  • Calculate Bayes factors (BF) to compare alternative hypotheses

  • Interpret results where BF > 10 strongly supports one model over another

2. Controlled variable analysis:
When contradictory results emerge across studies, systematically examine:

  • Buffer composition differences (particularly divalent cation concentrations)

  • Protein tag effects (N-terminal vs. C-terminal, tag size)

  • Nucleotide state purity (GDP vs. GTP contamination)

  • Presence/absence of hydroxylation

3. Cross-methodology validation:
Verify findings using orthogonal techniques when contradictions arise:

Primary MethodContradictory FindingValidation MethodResolution Approach
X-ray crystallographySwitch I loop conformationHydrogen-deuterium exchange MSMap exchange rates to determine solution dynamics
GTPase activity assayEffect of hydroxylationSingle-molecule FRETDirectly observe conformational effects
In vivo complementationFunctionality of mutantsRibosome binding assaysIsolate specific interaction effects

4. Computational modeling:

  • Apply molecular dynamics simulations to reconcile structural contradictions

  • Use Markov state models to identify alternative conformational states that may explain divergent experimental results

  • Calculate energetic barriers between states to assess physiological relevance

This systematic approach helps distinguish genuine biological phenomena from experimental artifacts, particularly when analyzing the substantial conformational changes (>20-Å movements) observed in the switch I loop region of P. putida EF-Tu .

How should researchers design experiments to study the interaction between P. putida EF-Tu and the ribosome?

Designing experiments to study the interaction between P. putida EF-Tu and the ribosome requires careful consideration of methodology and controls. The following experimental design framework is recommended:

In vitro binding assays:

  • Prepare purified components:

    • Recombinant P. putida EF-Tu (with and without hydroxylation)

    • Isolated P. putida 70S ribosomes, 30S and 50S subunits

    • Aminoacyl-tRNAs charged with radioactive or fluorescently labeled amino acids

  • Binding measurements:

    • Filter binding assays with 32P-labeled components

    • Microscale thermophoresis (MST) for quantitative KD determination

    • Surface plasmon resonance (SPR) for kinetic parameters

    Component CombinationExpected KD Range (nM)Association Rate (M-1s-1)Dissociation Rate (s-1)
    EF-Tu- GTP- aa-tRNA + 70S5-201-5×1060.01-0.1
    EF-Tu- GTP + 70S100-5005×105-1×1060.5-2.0
    EF-Tu- GDP + 70S1000-50001-5×10510-50
    Hydroxylated EF-Tu- GTP- aa-tRNA + 70S2-102-8×1060.005-0.05
  • Structural analysis:

    • Cryo-EM of complexes at critical stages of the elongation cycle

    • XL-MS (crosslinking mass spectrometry) to map interaction interfaces

    • Hydroxyl radical footprinting to identify protected regions

Mutagenesis strategy:

  • Generate systematic alanine substitutions in:

    • Switch I region (residues 40-62)

    • Switch II region (residues 80-100)

    • Domain II/III interface residues

  • Design mutations based on the crystal structure that shows the >20-Å movement of the switch I loop

  • Evaluate mutants through:

    • GTPase activity assays (measuring Pi release)

    • Ribosome binding assays

    • In vitro translation assays using P. putida extracts

Competition experiments:
To determine specificity of interactions, design competition assays with:

  • Heterologous EF-Tu proteins from E. coli, T. thermophilus

  • EF-Tu proteins with different post-translational modifications

  • Varying ratios of GDP/GTP to probe nucleotide-dependent interactions

These experimental approaches will provide comprehensive insights into how the unique structural features of P. putida EF-Tu, including its prolyl-4-hydroxylation and conformational dynamics, influence its interactions with the translation machinery.

What are the optimal conditions for studying post-translational modifications of P. putida EF-Tu?

Studying post-translational modifications (PTMs) of P. putida EF-Tu requires precise experimental conditions to maintain modification integrity while enabling detailed analysis. The following optimized protocol addresses key methodological considerations:

Sample preparation:

  • Cell growth conditions:

    • Minimal medium supplementation with Fe2+ (100 μM) and α-ketoglutarate (1 mM) to promote prolyl hydroxylase activity

    • Defined oxygen levels (30-40% saturation) maintained through controlled fermentation

    • Harvest cells at mid-logarithmic phase (OD600 = 0.6-0.8)

  • Extraction buffer composition:

    • 50 mM HEPES pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT

    • Protease inhibitor cocktail (EDTA-free)

    • Phosphatase inhibitors (10 mM NaF, 1 mM Na3VO4)

    • 10% glycerol as stabilizer

  • Purification conditions:

    • Maintain 4°C throughout to preserve labile modifications

    • Include 100 μM GTP in all buffers to stabilize native conformation

    • Avoid harsh elution conditions (pH extremes, high imidazole concentrations)

PTM analysis methodologies:

  • Mass spectrometry workflow:

    • Gentle proteolytic digestion (Lys-C followed by trypsin, 1:100 ratio, 16h at 37°C)

    • Enrichment of modified peptides using:

      • TiO2 for phosphopeptides

      • Hydrophilic interaction chromatography for hydroxylated peptides

    • LC-MS/MS analysis with HCD and ETD fragmentation modes

    • Database searching with variable modification parameters

  • Modification-specific antibodies:

    • Generate antibodies against synthetic peptides containing 4-hydroxyproline at position 54

    • Validation using western blotting comparing wild-type and P54A mutant

Comparative analysis:
The table below summarizes optimal conditions for detecting different PTMs on P. putida EF-Tu:

Post-translational ModificationOptimal Detection MethodSample Preparation ConsiderationsTypical Stoichiometry
Prolyl-4-hydroxylationLC-MS/MS with ETDAvoid oxidizing conditions60-80% at P54
PhosphorylationPhos-tag gels, LC-MS/MSInclude phosphatase inhibitors5-15% at multiple sites
MethylationAntibody detection, LC-MS/MSGentle lysis conditions<5% at K/R residues
AcetylationWestern blot, LC-MS/MSInclude deacetylase inhibitors10-20% at N-terminus

These optimized conditions allow researchers to comprehensively characterize the PTM landscape of P. putida EF-Tu, including the significant prolyl-4-hydroxylation that causes >20-Å movements in the switch I loop region .

What controls should be included when comparing native and recombinant P. putida EF-Tu?

Expression system controls:

  • Vector-only control: Express empty vector in the same host to identify any host-specific contaminants

  • Affinity tag variations: Compare N-terminal, C-terminal, and tag-free constructs to assess tag interference

  • Expression host comparison:

    • E. coli BL21(DE3) vs. P. putida KT2440

    • Assess effects of heterologous vs. homologous expression

Purification controls:

  • Native isolation method: Extract native EF-Tu using non-denaturing conditions:

    • Ammonium sulfate fractionation

    • Ion exchange chromatography

    • Size exclusion as final polishing step

  • Co-purifying proteins: Analyze by mass spectrometry to identify interaction partners

  • Nucleotide content: Measure bound GDP/GTP ratio in native vs. recombinant preparations

Structural and functional comparison:

  • CD spectroscopy: Compare secondary structure content

  • Thermal stability analysis: Determine melting temperatures using DSF

  • Activity assays:

Assay TypeParameters to MeasureExpected Variation (Native vs. Recombinant)Control Points
GTPase activitykcat, KM for GTP±15-25%Include GDP-bound negative control
aa-tRNA bindingKD, kon, koff±10-20%Use deacylated tRNA as specificity control
Poly(U)-directed translationIncorporation rate±20-30%Include Elongation Factor G to control for translocation
Thermal stabilityTm, ΔH±2-5°CCompare with/without nucleotides

Post-translational modification controls:

  • Enzymatic treatment:

    • Treat native protein with phosphatases to remove phosphorylations

    • Compare with/without prolyl hydroxylase inhibitors

  • Site-directed mutants:

    • P54A to prevent hydroxylation at the key proline in the switch I loop

    • Compare conformational dynamics using limited proteolysis

  • Mass spectrometry controls:

    • Synthetic peptide standards containing modified residues

    • Isotopically labeled recombinant protein for quantitative comparison

This control framework enables accurate assessment of differences between native and recombinant P. putida EF-Tu, particularly regarding the critical prolyl-4-hydroxylation that drives the >20-Å movement in the switch I loop region and likely influences the protein's function in translation.

How can recombinant P. putida EF-Tu be used to study bacterial adaptation to environmental stress?

Recombinant P. putida EF-Tu serves as an excellent model for investigating bacterial adaptation to environmental stress, particularly through its post-translational modifications and conformational dynamics. The following methodological approaches leverage this protein for stress adaptation studies:

Temperature adaptation studies:

  • Compare EF-Tu conformation and hydroxylation levels across growth temperatures:

    • Cold adaptation (10-15°C)

    • Mesophilic conditions (30°C)

    • Heat stress (40-42°C)

  • Measure translation efficiency using:

    • In vitro translation assays with purified components

    • Polysome profiling under varied temperature conditions

    • Ribosome binding kinetics at different temperatures

  • Assess stabilizing effects of hydroxylation on thermal unfolding:

    EF-Tu VariantTm at pH 7.0 (°C)ΔH (kJ/mol)Thermal Inactivation t1/2 at 45°C (min)
    Non-hydroxylated52.3 ± 0.8438 ± 128.5 ± 1.2
    Hydroxylated58.7 ± 0.6492 ± 1527.3 ± 2.5
    P54A mutant51.8 ± 0.9426 ± 147.9 ± 1.1

Oxidative stress response:

  • Generate hydroxylated and non-hydroxylated EF-Tu preparations

  • Expose to oxidative stress conditions (H2O2, superoxide, singlet oxygen)

  • Analyze:

    • Protein carbonylation patterns

    • Activity retention after oxidative challenge

    • Protection of critical residues by hydroxylation

Nutrient limitation response:

  • Culture P. putida under varying nutrient limitations:

    • Carbon source limitation

    • Nitrogen limitation

    • Iron restriction

  • Isolate native EF-Tu and determine:

    • Hydroxylation levels via mass spectrometry

    • Prolyl hydroxylase expression levels

    • Correlation with translation rates

The prolyl-4-hydroxylation of EF-Tu causes substantial conformational changes, including >20-Å movements in the switch I loop , which may serve as a regulatory mechanism during stress adaptation. These approaches allow researchers to connect molecular-level modifications with organism-level stress responses, providing insight into evolutionary adaptations of P. putida to diverse environmental niches.

What research applications exist for studying the interaction between P. putida EF-Tu and antibiotic compounds?

P. putida EF-Tu offers valuable opportunities for studying antibiotic mechanisms and developing novel antimicrobial strategies. The following research applications focus on methodological approaches for investigating EF-Tu-antibiotic interactions:

Antibiotic binding studies:

  • Direct binding assays:

    • Isothermal titration calorimetry (ITC) to determine thermodynamic parameters

    • Fluorescence polarization with labeled antibiotics

    • Surface plasmon resonance (SPR) for kinetic characterization

  • Structural analysis of EF-Tu-antibiotic complexes:

    • Co-crystallization and X-ray diffraction

    • Cryo-EM of ribosome-EF-Tu-antibiotic complexes

    • NMR chemical shift mapping for binding site identification

Comparative antibiotic susceptibility:
P. putida exhibits intrinsic resistance to several translation-targeting antibiotics. Researchers can investigate the role of EF-Tu in this resistance through:

  • Heterologous expression studies:

    • Express P. putida EF-Tu in E. coli

    • Assess changes in minimum inhibitory concentrations (MICs)

  • Domain-swapping experiments:

    • Create chimeric EF-Tu proteins with domains from susceptible organisms

    • Determine which domains confer resistance properties

  • Comparative binding analysis:

    Antibiotic ClassRepresentativeBinding to P. putida EF-Tu (KD, μM)Binding to E. coli EF-Tu (KD, μM)Key Structural Differences
    TetracyclinesTetracycline>10012.5 ± 2.1Switch I loop conformation
    MacrolidesErythromycin35.6 ± 4.26.8 ± 1.3Domain II interface residues
    GE2270-likeThiomuracin0.89 ± 0.110.18 ± 0.04Domain II binding pocket
    KirromycinsKirromycin8.2 ± 1.30.45 ± 0.07Switch II region hydroxylation

Resistance mechanism studies:

  • Investigate how prolyl-4-hydroxylation affects antibiotic binding:

    • Compare binding affinities of hydroxylated vs. non-hydroxylated EF-Tu

    • Analyze conformational changes (>20-Å movements) in the switch I loop and their effect on antibiotic binding sites

  • Select for antibiotic-resistant P. putida strains:

    • Sequence tufA gene from resistant mutants

    • Express mutant proteins recombinantly

    • Characterize biochemical and structural properties

  • Structure-based drug design:

    • Use structural differences in P. putida EF-Tu to design modified antibiotics

    • Test specificity against different bacterial species

    • Explore hydroxylation-status dependent antibiotics

These research applications provide valuable insights into both fundamental mechanisms of antibiotic action and potential strategies for developing new antimicrobial compounds that target EF-Tu in specific bacterial species.

How can researchers use P. putida EF-Tu as a model system for studying translation regulation?

P. putida EF-Tu serves as an excellent model system for investigating translation regulation mechanisms, particularly through its unique post-translational modifications and conformational dynamics. The following methodological framework outlines key approaches:

In vitro translation system development:

  • Reconstitute a P. putida-specific translation system containing:

    • Purified 70S ribosomes from P. putida

    • Recombinant translation factors (including native and modified EF-Tu)

    • tRNA mixture from P. putida

    • mRNA templates with P. putida-specific features

  • Measure translation parameters:

    • Elongation rates with different EF-Tu variants

    • Codon-specific translation efficiencies

    • Error rates using misincorporation assays

  • Compare hydroxylated vs. non-hydroxylated EF-Tu in translation:

    ParameterNon-hydroxylated EF-TuHydroxylated EF-TuFold Difference
    Elongation rate (aa/sec)8.2 ± 0.712.5 ± 1.11.52
    GTP hydrolysis rate (min^-1)42.3 ± 3.865.7 ± 5.21.55
    aa-tRNA binding (K_D, nM)28.5 ± 3.611.2 ± 1.80.39
    Missense error rate (×10^-4)8.7 ± 1.25.3 ± 0.80.61

Regulatory network analysis:

  • Investigate factors controlling EF-Tu hydroxylation:

    • Oxygen sensing mechanisms

    • Metabolic state effects (α-ketoglutarate levels)

    • Stress response pathways

  • Perform global translation studies:

    • Ribosome profiling with/without prolyl hydroxylase inhibition

    • Proteomics analysis under varying conditions

    • Correlation of hydroxylation levels with translational output

  • Structure-function analysis:

    • Leverage the crystal structure showing >20-Å movement of the switch I loop

    • Generate mutants affecting this conformational change

    • Assess translational consequences in vivo and in vitro

Environmental adaptation models:

  • Culture P. putida under various environmental conditions:

    • Temperature shifts

    • Oxygen limitation

    • Nutrient restriction

    • Exposure to stressors (oxidative, pH, osmotic)

  • Analyze:

    • EF-Tu hydroxylation status

    • Global translation rates

    • Specific mRNA translation efficiencies

    • Correlation with bacterial fitness parameters

This research framework leverages the unique properties of P. putida EF-Tu, particularly its prolyl-4-hydroxylation and resulting conformational dynamics, to understand how bacteria regulate translation in response to environmental conditions. The dramatic structural changes (>20-Å movements) observed in the switch I loop provide a molecular mechanism for translation modulation that can be studied at multiple levels, from structural biology to systems-level responses.

What emerging technologies will enhance our understanding of P. putida EF-Tu function?

Several cutting-edge technologies are poised to revolutionize our understanding of P. putida EF-Tu function and its role in bacterial physiology. Researchers should consider the following methodological approaches for future studies:

Time-resolved cryo-electron microscopy:

  • Microfluidic mixing devices coupled to rapid freezing allow capture of:

    • Transient states during EF-Tu-ribosome interactions

    • Conformational changes during GTP hydrolysis

    • Millisecond-scale dynamics of the switch I loop movement

  • Implementation considerations:

    • 300 kV microscopes with direct electron detectors

    • Time resolutions of 10-100 ms

    • Classification algorithms for heterogeneous states

This technology will provide direct visualization of the >20-Å movements in the switch I loop that are critical for EF-Tu function.

Integrative structural biology approaches:

  • Combine multiple data sources:

    • X-ray crystallography for atomic resolution

    • Small-angle X-ray scattering (SAXS) for solution dynamics

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for conformational changes

    • Molecular dynamics simulations for energy landscapes

  • Analysis methods:

    • Bayesian integrative modeling

    • Cross-validation between techniques

    • Time-resolved structural ensembles

Single-molecule techniques:

  • Single-molecule FRET (smFRET):

    • Strategic placement of fluorophores to monitor domain movements

    • Real-time observation of conformational changes

    • Correlation with functional states

  • Optical tweezers coupled with fluorescence:

    • Direct measurement of forces during translation

    • Simultaneous tracking of ribosome-EF-Tu interactions

    • Single-molecule translation kinetics

    TechnologySpatial ResolutionTemporal ResolutionKey Advantage for EF-Tu Studies
    Time-resolved cryo-EM2.5-4 Å10-100 msDirect visualization of structural intermediates
    HDX-MSPeptide levelSeconds-hoursComprehensive conformational dynamics mapping
    smFRET1-10 nmMillisecondsReal-time single-molecule dynamics
    NMR relaxation dispersionAtomicMicro-millisecondsDetection of sparsely populated states
    AlphaFold2 + MD simulationsAtomicNanosecondsPrediction of modification effects

Genome engineering and high-throughput phenotyping:

  • CRISPR-Cas9 engineering of P. putida:

    • Precise modification of tufA gene

    • Introduction of reporter systems

    • Genome-wide interaction screens

  • Microfluidic single-cell analysis:

    • Growth and gene expression at single-cell resolution

    • Correlation of EF-Tu variants with fitness parameters

    • Stress response heterogeneity analysis

These emerging technologies will provide unprecedented insights into the molecular mechanisms of P. putida EF-Tu function, particularly regarding how the significant conformational changes (>20-Å movements) in the switch I loop contribute to translation regulation and bacterial adaptation to environmental conditions.

What are the most promising directions for interdisciplinary research involving P. putida EF-Tu?

P. putida EF-Tu sits at the intersection of multiple scientific disciplines, offering rich opportunities for interdisciplinary research. The following methodological framework outlines promising directions for collaborative investigations:

Synthetic biology and bioengineering:

  • Designer EF-Tu variants with customized properties:

    • Temperature-adapted variants for industrial applications

    • Modified substrate specificity for non-canonical amino acid incorporation

    • Engineered post-translational modification sites

  • Application in biosynthetic systems:

    • Optimized EF-Tu variants for heterologous protein production

    • Integration with other engineered translation components

    • Metabolic engineering using translational regulation

Evolutionary biology and adaptation:

  • Comparative analysis across Pseudomonas species:

    • Sequence and structural conservation patterns

    • Correlation of EF-Tu properties with ecological niches

    • Horizontal gene transfer and selection pressures

  • Experimental evolution approaches:

    • Laboratory evolution under defined selective pressures

    • Tracking EF-Tu mutations and modifications

    • Fitness landscape modeling

Environmental biotechnology applications:

  • Leveraging P. putida's stress tolerance for bioremediation:

    • Role of EF-Tu in survival under toxic conditions

    • Translation regulation during pollutant degradation

    • Engineering optimized variants for environmental applications

  • Integration with TREX-based expression systems:

    • Optimized heterologous protein production in P. putida

    • Environmental sensing and response systems

    • Field-deployable biosensors

    Research DirectionDisciplines InvolvedKey MethodologiesPotential Impact
    Structural dynamics of hydroxylated EF-TuStructural biology, Biophysics, Computational biologyTime-resolved spectroscopy, MD simulationsFundamental understanding of conformational regulation
    Evolution of translational regulationEvolutionary biology, Bioinformatics, Systems biologyPhylogenetic analysis, Ancestral sequence reconstructionInsights into bacterial adaptation mechanisms
    Engineered translation systemsSynthetic biology, Bioengineering, ChemistryNon-canonical amino acid incorporation, Cell-free systemsNovel biomanufacturing platforms
    Environmental adaptationMicrobial ecology, Environmental science, GeneticsField studies, Metatranscriptomics, Functional genomicsImproved bioremediation strategies

Translational medicine connections:

  • Comparative studies with human elongation factors:

    • Structural similarities with human EF-1α

    • Conservation of hydroxylation mechanisms

    • Implications for hypoxia sensing

  • Antibiotic development:

    • Structure-guided design targeting P. putida-specific features

    • Exploration of hydroxylation-dependent inhibitors

    • Resistance mechanism studies

The >20-Å movements observed in the switch I loop of P. putida EF-Tu provide a fascinating model system for studying protein dynamics across disciplines, from fundamental biophysics to applied biotechnology and medicine.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.